FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, Filip Machaj, Katarzyna Kotfis, Saeid Ghavami, Marek Łoś
Topics & Concepts
MedicineLopinavirHydroxychloroquineFavipiravirRitonavirAzithromycinClinical trialChloroquinePharmacologyIntensive care medicineVirologyImmunologyDiseaseAntibioticsCoronavirus disease 2019 (COVID-19)MalariaVirusInternal medicineViral loadBiologyMicrobiologyInfectious disease (medical specialty)Antiretroviral therapyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19